-CNBC’s “Fast Money: Halftime Report”
ReShape Lifesciences Announces Closing of Upsized $10.2M Underwritten Public Offering; Shares Spike Higher
ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the closing of its upsized underwritten public offering of 1,275,000 units, with each